Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02735980
Title A Study of LY2606368 in Participants With Extensive Stage Disease Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung small cell carcinoma

Therapies

Prexasertib

Age Groups: adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.